أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

The CEO and founder of Glid, a 2025 Startup Battlefield winner, shares his experience and lessons learned from the program, highlighting his positive interactions with the TechCrunch team.

The US stock market has rebounded with major indices rising 1.2% following eased investor concerns, and high-growth tech stocks are capturing attention due to their potential for innovation and resilience.

The article suggests that a digital bank is undervalued and presents a buying opportunity for investors, citing its profitability and growth potential.

Big Tech stocks, also known as the 'Magnificent Seven', have reached historically low prices, prompting investors to consider buying opportunities.

ImmunityBio Inc., a biotech company led by billionaire Patrick Soon-Shiong, has seen its stock surge, forcing short sellers to exit their positions at a loss, with the stock tripling over the past three weeks.

Tech stocks rebounded after President Trump's comments on not using military force in Greenland, easing concerns of a global conflict that could impact the tech industry.

Foreign investors are returning to Indian tech stocks, driven by the growth potential of artificial intelligence in the sector, which is expected to boost business for Indian software exporters.

Ethos, a profitable insurance technology company, is poised to become the first tech IPO of the year, backed by prominent venture capitalists and celebrities.

Nvidia and Tesla led tech stocks lower due to concerns over Trump's trade war threats and AI bubble fears, contributing to broader market declines.

The article discusses the growth potential of the AI software market, which is expected to outpace generative AI solutions, and compares Microsoft and Palantir as potential investment options.

Tech stocks are leading the decline on Wall Street due to renewed trade tensions related to Greenland, causing a risk-off move across U.S.

Biotics AI, a winner of the TechCrunch Disrupt Battlefield 2023, has received FDA approval for its AI-powered fetal ultrasound product, enhancing detection capabilities for fetal abnormalities.